Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-074988

Director acquired 33,150 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lucidi Bruno Director 2024-06-16 Option exercise +33,150 83,150 D
Derivatives
Lucidi Bruno Director 2024-06-16 Option exercise · Restricted Stock Units −33,150 0 D
Loading xslF345X05/ownership.xml…